Tumor necrosis factor superfamily signaling: life and death in cancer

Obada Ababneh1, Daisuke Nishizaki2, Shumei Kato2

  • 1Faculty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan. oeababneh185@med.just.edu.jo.

PubMed

Insights

Tumor necrosis factor (TNF) superfamily (TNFSF) and TNF receptor superfamily (TNFRSF) members have complex roles in cancer. This review explores their dual pro- and anti-tumor activities and signaling pathways in cancer cells.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, but response rates remain limited.
  • Many patients treated with ICIs experience primary resistance or subsequent disease progression.
  • Tumor necrosis factor (TNF) superfamily (TNFSF) and TNF receptor superfamily (TNFRSF) members are key regulators of immune responses and cellular fate, with complex roles in cancer.

Purpose of the Study:

  • To review the multifaceted roles of TNFSF/TNFRSF members in cancer.
  • To highlight specific TNFSF/TNFRSF members, particularly those involved in cell death and co-stimulation.
  • To elucidate their signaling pathways and impact on cancer cell survival and death.

Main Methods:

  • Literature review of TNFSF/TNFRSF family members in cancer research.
  • Focus on death domain-containing and co-stimulatory members.
  • Analysis of signaling pathways implicated in cancer biology.

Main Results:

  • TNFSF/TNFRSF molecules exhibit context-dependent pro- or anti-tumoral activities.
  • TNF acts as a dual mediator in oncogenesis.
  • While anti-TNF agents are established for autoimmune diseases, their direct anti-cancer applications are less defined.

Conclusions:

  • TNFSF/TNFRSF members represent a complex and promising area for cancer therapeutic development.
  • Understanding their intricate signaling is crucial for harnessing their potential in cancer treatment.
  • Further research is needed to clarify their precise roles and therapeutic applications in oncology.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.3K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K